News and Events
Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine
Added on 2021-01-04A vaccine for
everywhere and everyone in the world, AKS-452 is stable for weeks at room temperature,
inexpensive to produce, and suitable for both first-time and booster
vaccination
Webinar recording now available: LakePharma’s Coronavirus Spike Protein Antibodies: A fresh quiver of arrows against the crowned invader!
Added on 2020-10-01Webinar recording available now!!
Read MoreLakePharma Supplying Mount Sinai with SARS-CoV-2 Proteins for Serological Assays
Added on 2020-05-06LakePharma
today announces that the company will be supplying the Mount Sinai Health
System (Mount Sinai) recombinant SARS-CoV-2 spike proteins to the Mount Sinai
Laboratory as a component in its blood test for antibody response against SARS-CoV-2,
the virus that causes the COVID-19 pandemic.
Webinar recording now available - Part 2 :LakePharma Reagents & Assays for COVID-19 Antibody Response
Added on 2020-05-04Read More